| OTIC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the OTIC shares outstanding history going back to 8/13/2014:
Also see: OTIC Market Cap History OTIC YTD Return |
OTIC Shares Outstanding History — Otonomy Share Count Over Time
As of 10/28/2022 Otonomy has 57.15 million OTIC shares outstanding. Investors often track the OTIC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows OTIC share count trends over time, with 34 historical shares outstanding datapoints presented, dating back to 8/13/2014.
| OTIC Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OTIC Historical Shares Outstanding: +14.05% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OTIC Stock Price Chart |
| About Otonomy Inc |
| Otonomy is a biopharmaceutical company focused on the development of innovative therapeutics for neurotology. Co. developed the application of drug delivery technology to the ear. Co.'s primary focus is on the development of three programs in its pipeline: OTO-313 in Phase 2 for tinnitus; OTO-413 in Phase 2a for hearing loss; and OTO-825, a gene therapy for congenital hearing loss, in investigational new drug (IND)-enabling activities. Additionally, Co. is conducting preclinical development of OTO-510 for otoprotection and OTO-6XX for severe hearing loss. We show 34 historical shares outstanding datapoints in our coverage of OTIC's shares outstanding history. Understanding the changing numbers of OTIC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like OTIC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching OTIC by allowing them to research OTIC shares outstanding history as well as any other stock in our coverage universe. |
| OTIC Current Stock Quote |
Quotes delayed 20 minutes  Free OTIC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| OTIC Share Performance |
| Shares Outstanding Peers |
| Otonomy (OTIC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
OTLK Shares Outstanding History OTRK Shares Outstanding History OVAS Shares Outstanding History OVID Shares Outstanding History OWLT Shares Outstanding History OYST Shares Outstanding History PACB Shares Outstanding History PACS Shares Outstanding History PAHC Shares Outstanding History PALI Shares Outstanding History More Healthcare companies » |
OTIC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
